Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T0SK
|
|||
Former ID |
DNC009087
|
|||
Drug Name |
ST-2987
|
|||
Synonyms |
ST-2987; CHEMBL471042; SCHEMBL3444989; SCHEMBL3444984; BDBM50278220
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H15N3O5
|
|||
Canonical SMILES |
C1=CC(=CC=C1CON=CC2=CC=C(C=C2)C=CC(=O)NO)[N+](=O)[O-]
|
|||
InChI |
1S/C17H15N3O5/c21-17(19-22)10-7-13-1-3-14(4-2-13)11-18-25-12-15-5-8-16(9-6-15)20(23)24/h1-11,22H,12H2,(H,19,21)/b10-7+,18-11+
|
|||
InChIKey |
IWWFFHDXUHSRDM-PFMZDYLOSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2346-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.